2022International Journal of Enteric PathogensOpen access

Anti-leishmania Effect of Magnesium Oxide Nanoparticles on Leishmania tropica/infantum and Leishmania-Infected Macrophages

Amir KarimiPourSaryazdi, Mohammad Mahdi Jafari, Roya Omidi, Fatemeh Ghaffarifar, Seyyed Hojjat Sadeghi

Open full text 3 citations

Abstract

Background: Leishmania is an intracellular protozoan parasite that enters and reproduces in macrophage cells. Macrophages are important immune cells that phagocyte many pathogens such as bacteria, fungi, and parasites such as Leishmania spp. but are incapable of killing this parasite, living in the phagosomes of infected macrophages, multiplying, and resulting in the divesting of infected macrophages and the appearance of Leishmania lesions. Many of the present drugs for Leishmania treatment have side effects, or parasites have resistance to some of these drugs. Therefore, there is a need for a better drug for Leishmania treatment. Magnesium oxide (MgO) is a metal nanoparticle (NP) with numerous biological applications, including antioxidant and antimicrobial effects on various pathogens such as some bacteria, fungi, and parasites, including Leishmania spp. Objectives: Accordingly, this article has discussed the effects of MgO NPs on Leishmania tropica and Leishmania infantum and Leishmania-infected macrophages. Materials and Methods: The effect of various doses of MgO NPs on L. tropica and L. infantum promastigotes and amastigotes was studied in vitro. Flow cytometry and MTT were also utilized to assess the cytotoxic effects of MgO on L. tropica and L. infantum promastigotes, as well as the likelihood of apoptosis. Amastigote assay was employed to determine the infected macrophage percentage, and the number of parasites present in every macrophage cell. Results: The percentage of macrophages contaminated with amastigotes of L. tropica and L. infantum that were treated with MgO NPs was 15% and 11%, respectively. Flow cytometry revealed that MgO NPs induced approximately 38.56% and 30.5% apoptosis on L. tropica and Leishmania infantum, respectively. The half maximal inhibitory concentration of MgO NPs to L. tropica and L. infantum according to promastigote assay for 72 hours was 7.32 μg/mL and 12.58 μg/mL, respectively. Conclusion: According to the findings, MgO NPs had a great in-vitro fatality effect on L. tropica and L. infantum promastigotes and amastigotes (inside leishmania-infected macrophages).

Open-access reader

About this research paper

What this paper is about

Background: Leishmania is an intracellular protozoan parasite that enters and reproduces in macrophage cells. Macrophages are important immune cells that phagocyte many pathogens such as bacteria, fungi, and parasites such as Leishmania spp. but are incapable of killing this parasite, living in the phagosomes of infected macrophages, multiplying, and resulting in the divesting of infected macrophages and the appearance of Leishmania lesions. Many of the present drugs for Leishmania treatment have side effects, or parasites have resistance to some of these drugs. Therefore, there is a need for a better drug for Leishmania treatment. Magnesium oxide (MgO) is a metal nanoparticle (NP) with numerous biological applications, including antioxidant and antimicrobial effects on various pathogens such as some bacteria, fungi, and parasites, including Leishmania spp. Objectives: Accordingly, this article has discussed the effects of MgO NPs on Leishmania tropica and Leishmania infantum and Leishmania-infected macrophages. Materials and Methods: The effect of various doses of MgO NPs on L. tropica and L. infantum promastigotes and amastigotes was studied in vitro. Flow cytometry and MTT were also utilized to assess the cytotoxic effects of MgO on L. tropica and L. infantum promastigotes, as well as the likelihood of apoptosis. Amastigote assay was employed to determine the infected macrophage percentage, and the number of parasites present in every macrophage cell. Results: The percentage of macrophages contaminated with amastigotes of L. tropica and L. infantum that were treated with MgO NPs was 15% and 11%, respectively. Flow cytometry revealed that MgO NPs induced approximately 38.56% and 30.5% apoptosis on L. tropica and Leishmania infantum, respectively. The half maximal inhibitory concentration of MgO NPs to L. tropica and L. infantum according to promastigote assay for 72 hours was 7.32 μg/mL and 12.58 μg/mL, respectively. Conclusion: According to the findings, MgO NPs had a great in-vitro fatality effect on L. tropica and L. infantum promastigotes and amastigotes (inside leishmania-infected macrophages).

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: Leishmania is an intracellular protozoan parasite that enters and reproduces in macrophage cells. Macrophages are important immune cells that phagocyte many pathogens such as bacteria, fungi, and parasites such as Leishmania spp. but are incapable of killing this parasite, living in the phagosomes of infected macrophages, multiplying, and resulting in the divesting of infected macrophages and the appearance of Leishmania lesions. Many of the present drugs for Leishmania treatment have side effects, or parasites have resistance to some of these drugs. Therefore, there is a need for a better drug for Leishmania treatment. Magnesium oxide (MgO) is a metal nanoparticle (NP) with numerous biological applications, including antioxidant and antimicrobial effects on various pathogens such as some bacteria, fungi, and parasites, including Leishmania spp. Objectives: Accordingly, this article has discussed the effects of MgO NPs on Leishmania tropica and Leishmania infantum and Leishmania-infected macrophages. Materials and Methods: The effect of various doses of MgO NPs on L. tropica and L. infantum promastigotes and amastigotes was studied in vitro. Flow cytometry and MTT were also utilized to assess the cytotoxic effects of MgO on L. tropica and L. infantum promastigotes, as well as the likelihood of apoptosis. Amastigote assay was employed to determine the infected macrophage percentage, and the number of parasites present in every macrophage cell. Results: The percentage of macrophages contaminated with amastigotes of L. tropica and L. infantum that were treated with MgO NPs was 15% and 11%, respectively. Flow cytometry revealed that MgO NPs induced approximately 38.56% and 30.5% apoptosis on L. tropica and Leishmania infantum, respectively. The half maximal inhibitory concentration of MgO NPs to L. tropica and L. infantum according to promastigote assay for 72 hours was 7.32 μg/mL and 12.58 μg/mL, respectively. Conclusion: According to the findings, MgO NPs had a great in-vitro fatality effect on L. tropica and L. infantum promastigotes and amastigotes (inside leishmania-infected macrophages).

Key concepts: Amastigote, Leishmania tropica, Leishmania, Leishmania infantum, Microbiology, Leishmaniasis, Cutaneous leishmaniasis, Biology

Related papers

Back to paper searchBrowse research topicsOriginal source
Anti-leishmania Effect of Magnesium Oxide Nanoparticles on Leishmania tropica/infantum and Leishmania-Infected Macrophages — Research Paper | ScholarLens